Literature DB >> 12030603

Impairment of GH secretion in adults with primary empty sella.

M Gasperi1, G Aimaretti, E Cecconi, A Colao, C Di Somma, S Cannavò, C Baffoni, M Cosottini, L Curtò, F Trimarchi, G Lombardi, L Grasso, E Ghigo, E Martino.   

Abstract

Primary empty sella (PES) is generally not associated with overt endocrine abnormalities, although mild hyperprolactinemia and, in children, deficient GH secretion have been reported. The aim of this multi-center collaborative study was to evaluate basal and stimulated GH secretion in a large series of adult PES patients. The study group consisted of 51 patients [41 women and 10 men, age range: 20-78 yr; (mean+/-SD) 47+/-11 yr]; results were compared with those in normal subjects (Ns) (Ns: no.=110, 55 women, age: 20-50 yr, 37+/-14 yr), and in hypopituitaric patients (HYP) with GH deficiency (HYP: no.=44,17 women, age: 20-72, 49+/-16 yr). Baseline IGF-I levels and GH responses to insulin-induced hypoglycemia (insulin tolerance test, ITT) and/or GHRH+arginine (ARG) stimulation tests were evaluated. PES patients were also subdivided according to BMI in lean (BMI <28 kg/M2 no.=22) or obese (BMI >28 kg/m2 no.=29). PES patients had serum total IGF-I concentrations (mean+/-SE: 142.2+/-9.6 ng/ml) higher than HYP patients (77.4+/-6.4 ng/ml, p<0.001), but lower than Ns (213.3+/-17.2 ng/ml, p<0.005), with no differences between lean and obese PES subjects. The increase in serum GH concentrations following ITT and/or GHRH+ARG stimulation tests, although higher than that observed in HYP patients, was markedly reduced with respect to Ns. No difference was observed in the GH response to provocative tests between lean and obese PES patients. When individual GH responses to ITT or GHRH+ARG were taken into account, a large proportion of PES patients (52% after ITT, 61% after GHRH+ARG) showed a GH peak increase below the 1st centile of normal limits. Serum IGF-I levels in PES patients with blunted GH responses to provocative tests were significantly (p<0.001) lower in PES patients with normal GH responses, and a positive correlation was observed between IGF-I levels and serum GH peak concentrations after GHRH+ARG. In conclusion, the results of the present study provide evidence that adult PES patients often have an impairment of GH secretion, as indicated by the blunted GH response to ITT and GHRH+ARG provocative tests, and by the reduction in serum IGF-I levels. These changes are independent of body mass.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030603     DOI: 10.1007/BF03344013

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

Authors:  G Aimaretti; G Corneli; P Razzore; S Bellone; C Baffoni; E Arvat; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

2.  High frequency of empty sella syndrome in children with growth hormone deficiency.

Authors:  M Pocecco; C de Campo; S Marinoni; G Tommasini; T Basso; C Muzzolini; B Sacher
Journal:  Helv Paediatr Acta       Date:  1989-02

3.  Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.

Authors:  J Bellone; G Aimaretti; S Bellone; C Baffoni; G Corneli; C Origlia; M Cappa; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

4.  Sequential contrast-enhanced magnetic resonance imaging in the diagnosis of growth hormone deficiencies.

Authors:  A Liotta; C Maggio; M Giuffrè; M Carta; L Manfrè
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

5.  The diagnosis of growth hormone deficiency (GHD) in adults.

Authors:  M O Thorner; B A Bengtsson; K Y Ho; K Albertsson-Wikland; J S Christiansen; G Faglia; M Irie; O Isaksson; J O Jörgensen; M Ranke
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

Review 6.  Clinical aspects of growth hormone deficiency in adults.

Authors:  H de Boer; G J Blok; E A Van der Veen
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

7.  Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test.

Authors:  J Svensson; G Johannsson; B A Bengtsson
Journal:  Clin Endocrinol (Oxf)       Date:  1997-05       Impact factor: 3.478

8.  Results of dynamic endocrine testing of hypothalamic pituitary function in patients with a primary "empty" sella syndrome.

Authors:  M Buchfelder; S Brockmeier; J Pichl; U Schrell; R Fahlbusch
Journal:  Horm Metab Res       Date:  1989-10       Impact factor: 2.936

9.  Hypopituitarism following external radiotherapy for pituitary tumours in adults.

Authors:  M D Littley; S M Shalet; C G Beardwell; S R Ahmed; G Applegate; M L Sutton
Journal:  Q J Med       Date:  1989-02

10.  Empty sella in children and adolescents with possible hypothalamic-pituitary disorders.

Authors:  E Cacciari; S Zucchini; P Ambrosetto; G Tani; G Carlà; A Cicognani; P Pirazzoli; T Sganga; A Balsamo; A Cassio
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

View more
  16 in total

1.  How much of our pituitary is really necessary?

Authors:  B Ambrosi; G Faglia
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  GH and primary empty sella.

Authors:  F Santeusanio
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

Review 3.  Primary empty sella (PES): a review of 175 cases.

Authors:  M Guitelman; Natalia Garcia Basavilbaso; M Vitale; A Chervin; D Katz; K Miragaya; J Herrera; D Cornalo; M Servidio; L Boero; M Manavela; K Danilowicz; A Alfieri; G Stalldecker; M Glerean; P Fainstein Day; C Ballarino; Maria Susana Mallea Gil; A Rogozinski
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 4.  Primary empty sella: Why and when to investigate hypothalamic-pituitary function.

Authors:  A Giustina; G Aimaretti; M Bondanelli; F Buzi; S Cannavò; S Cirillo; A Colao; L De Marinis; D Ferone; M Gasperi; S Grottoli; T Porcelli; E Ghigo; E degli Uberti
Journal:  J Endocrinol Invest       Date:  2010-03-05       Impact factor: 4.256

5.  Growth hormone deficiency in patients with obesity.

Authors:  Roberto Salvatori
Journal:  Endocrine       Date:  2015-03-10       Impact factor: 3.633

Review 6.  Idiopathic adult growth hormone deficiency.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

Review 7.  Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

8.  Pituitary autoimmunity is associated with hypopituitarism in patients with primary empty sella.

Authors:  I Lupi; L Manetti; V Raffaelli; L Grasso; C Sardella; M Cosottini; A Iannelli; M Gasperi; F Bogazzi; P Caturegli; E Martino
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

9.  Systemic hypertension counteracts potential benefits of growth hormone replacement therapy on left ventricular remodeling in adults with growth hormone deficiency.

Authors:  C de Gregorio; L Curtò; F Marini; G Andò; O Trio; F Trimarchi; S Coglitore; S Cannavò
Journal:  J Endocrinol Invest       Date:  2012-10-15       Impact factor: 4.256

Review 10.  Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic-pituitary-gonadal, hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes dysfunction.

Authors:  L Curtò; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2016-05-21       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.